NDC 0121-0670 – Ethosuximide
Ethosuximide 250 mg/5mL · Solution · Oral
Product NDC0121-0670
Product details
- Brand name
- Ethosuximide
- Generic name
- Ethosuximide
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Dosage form
- Solution
- Route
- Oral
- Marketing category
- ANDA · ANDA040253
- Marketed since
- November 22, 2000
- Listing expires
- December 31, 2026
- Pharmacologic class
- Anti-epileptic Agent
Active ingredients
- Ethosuximide 250 mg/5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0121-0670-16 | 473 mL in 1 BOTTLE (0121-0670-16) | Nov 22, 2000 |
Recalls mentioning this NDC
- D-0723-2021 Aug 18, 2021 · Class II
Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.
Other Ethosuximide products
- 68999-064 Ethosuximide 250 mg/5mL · Solution · Chartwell Governmental & Specialty RX, LLC.
- 62135-064 Ethosuximide 250 mg/5mL · Solution · Chartwell RX, LLC
- 59762-2350 Ethosuximide 250 mg/5mL · Solution · Mylan Pharmaceuticals Inc.
- 69452-152 Ethosuximide 250 mg/1 · Capsule, Liquid Filled · Bionpharma Inc.
- 63629-8005 Ethosuximide 250 mg/1 · Capsule, Liquid Filled · Bryant Ranch Prepack
- 62135-790 Ethosuximide 250 mg/1 · Capsule · Chartwell RX, LLC
- 42806-708 Ethosuximide 250 mg/1 · Capsule · Epic Pharma, LLC
- 42806-711 Ethosuximide 250 mg/1 · Capsule · Epic Pharma, LLC
- 64380-878 Ethosuximide 250 mg/1 · Capsule · Strides Pharma Science Limited